Daniel P Bermingham

Title: Inventor Spotlight: Daniel P. Bermingham

Introduction

Daniel P. Bermingham is a noteworthy inventor based in San Francisco, CA, whose contributions to the field of biotechnology have made a significant impact. With a focus on pharmaceutical innovations, Bermingham has developed technologies that aim to improve health outcomes for individuals in need.

Latest Patents

Bermingham holds a patent titled "Anti-MS4A4A antibodies and methods of use thereof." This patent encompasses compositions that include antibodies—such as monoclonal antibodies, humanized antibodies, and antibody fragments—that specifically target a MS4A4A polypeptide. The applications of this patent arerevolutionary, as they indicate potential methods for preventing, reducing risk, or treating conditions in individuals requiring medical assistance.

Career Highlights

Currently, Daniel P. Bermingham works at Alector LLC, an innovative biotechnology company dedicated to developing revolutionary therapies for neurodegeneration and advancing our understanding of the human immune system. His expertise and dedication to his field have led to his successful patent acquisition, showcasing his ability to contribute meaningfully to biopharmaceutical development.

Collaborations

Bermingham collaborates with a talented peer, Wei-Hsien Ho. Together, they leverage their collective skills and knowledge to advance groundbreaking research and foster innovative solutions in the realm of immunology and drug development.

Conclusion

Daniel P. Bermingham exemplifies the spirit of innovation through his work and dedication in the biotechnology sector. His contributions, including his patented technologies, highlight the importance of continuous research and development in the fight against diseases, ultimately aiming to improve the quality of life for many.